No Data
No Data
BRIEF-Tetra Bio Pharma Inc Announces Approval Of $4.5M CDN Participative Loan From Ministère De L'économie Et De L'innovation
BRIEF-Tetra Bio-Pharma Reports Positive Initial Data from Both Ongoing Trials of QIXLEEF
BRIEF-Tetra Bio-Pharma Receives Positive Opinion For Orphan Drug Designation For Qixleef From The European Medicines Agency
BRIEF-Tetra Bio-Pharma Provides Update On Clinical Development Program For Qixleef
Tetra Bio Pharma Inc: AB FORM 13-501F1 (CLASS 1 AND 3B REPORTING ISSUERS - PARTICIPATION FEE)
Tetra Bio Pharma Inc: ON FORM 13-502F1 (CLASS 1 AND 3B REPORTING ISSUERS - PARTICIPATION FEE)